Intravenously injected FK506 failed to inhibit hippocampal calcineurin

被引:9
作者
Morioka, M
Fukunaga, K
Kai, Y
Todaka, T
Yano, S
Hamada, J
Miyamoto, E
Ushio, Y
机构
[1] Kumamoto Univ, Sch Med, Dept Neurosurg, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Sch Med, Dept Pharmacol, Kumamoto 8608556, Japan
关键词
hippocampus; calcineurin; FK506;
D O I
10.1006/bbrc.2001.5468
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FK506 (tacrolimus) is known as an inhibitor for calcineurin and is used in numerous research fields. It is not clear whether intravenously injected FK506 inhibits neuronal calcineurin. We measured the calcineurin activities of normal and postischemic rat hippocampi after intravenous injection of FK506 (3 mg/kg). Intravenously injected FK506 had no inhibitory effect on calcineurin activity in the hippocampi of normal and postischemic rats, whereas FK506 inhibited the calcineurin in vitro (purified enzyme, hippocampal homogenate, and hippocampal slice culture homogenate). Thus, it is considered that intravenously injected FK506 does not act on intraneuronal calcineurin and that several effects of FK506 are not due to the inhibition of neuronal calcineurin. (C) 2001 Academic Press.
引用
收藏
页码:802 / 806
页数:5
相关论文
共 50 条
[31]   Therapeutic Effects of FK506 on IgA Nephropathy Rat [J].
Wei, Linting ;
Du, Yan ;
Jia, Lining ;
Ma, Xiaotao ;
Chen, Zhao ;
Lu, Jiamei ;
Tian, Lifang ;
Duan, Zhaoyang ;
Dong, Fengming ;
Lv, Zhian ;
Yao, Ganglian ;
Fu, Rongguo ;
Wang, Li .
KIDNEY & BLOOD PRESSURE RESEARCH, 2017, 42 (06) :983-998
[32]   RAPAMYCIN, FK506 AND CYCLOSPORINE-A INHIBIT HUMAN PROLACTIN GENE-EXPRESSION [J].
WERA, S ;
BELAYEW, A ;
MARTIAL, JA .
FEBS LETTERS, 1995, 358 (02) :158-160
[33]   Novel chemobiosynthetic approach for exclusive production of FK506 [J].
Kosec, Gregor ;
Goranovic, Dusan ;
Mrak, Peter ;
Fujs, Stefan ;
Kuscer, Enej ;
Horvat, Jaka ;
Kopitar, Gregor ;
Petkovic, Hrvoje .
METABOLIC ENGINEERING, 2012, 14 (01) :39-46
[34]   Ascomycin and FK506:: Pharmacology and therapeutic potential as anticonvulsants and neuroprotectants [J].
Sierra-Paredes, German ;
Sierra-Marcuno, German .
CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (01) :36-46
[35]   FK506 and Its Analogs - Therapeutic Potential for Neurological Disorders [J].
Klettner, Alexa ;
Herdegen, Thomas .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (03) :153-162
[36]   FK506 facilitates chemical kindling induced by pentylenetetrazole in rats [J].
Suzuki, K ;
Omura, S ;
Ohashi, Y ;
Kawai, M ;
Iwata, Y ;
Tani, K ;
Sekine, Y ;
Takei, N ;
Mori, N .
EPILEPSY RESEARCH, 2001, 46 (03) :279-282
[37]   Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in α-synucleinopathies [J].
Zaichick, Sofia ;
Caraveo, Gabriela .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
[38]   The Calcineurin Inhibitor FK506 Prevents Cognitive Impairment by Inhibiting Reactive Astrogliosis in Pilocarpine-Induced Status Epilepticus Rats [J].
Liu, Jinzhi ;
Si, Zhihua ;
Li, Shuqing ;
Huang, Zhan ;
He, Yan ;
Zhang, Tao ;
Wang, Aihua .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 11
[39]   FK506 IN CLINICAL ORGAN-TRANSPLANTATION [J].
FUNG, JJ ;
ABUELMAGD, K ;
TODO, S ;
SHAPIRO, R ;
TZAKIS, A ;
JORDAN, M ;
ARMITAGE, J ;
JAIN, A ;
MARTIN, M ;
BRONSTER, O ;
STIEBER, A ;
KORMOS, R ;
SELBY, R ;
GORDON, R ;
STARZL, TE .
CLINICAL TRANSPLANTATION, 1991, 5 (06) :517-522
[40]   Regulation by FK506 and rapamycin of Ca2+release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR [J].
MacMillan, D. ;
McCarron, J. G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (04) :1112-1120